Sanofi (SNY) Dividends Paid - Common (2009 - 2010)
Sanofi (SNY) posted Dividends Paid - Common of -$4.3 billion for Q4 2010, down 200.08% sequentially from $4.2 billion in Q4 2009, and down 200.08% YoY from $4.2 billion in Q4 2009.
Sanofi (SNY) Dividends Paid - Common (2009 - 2010) Analysis & Trends
Sanofi has reported Dividends Paid - Common for 2 years, with the latest figure at -$4.3 billion in Q4 2010.
- Quarterly Dividends Paid - Common fell 200.08% year-over-year to -$4.3 billion in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $150.0 million (down 91.46% YoY) and the FY2025 annual result came in at $5.6 billion, up 10.51% from the prior year.
- Dividends Paid - Common retreated to -$4.3 billion in Q4 2010 per SNY's latest filing, from $4.2 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $4.2 billion in Q4 2009 and troughed at -$4.3 billion in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -4.25 Bn |
| Dec 31, 2010 | -4.25 Bn |
| Dec 31, 2009 | 4.25 Bn |
| Dec 31, 2009 | 4.25 Bn |